难治性急性髓性白血病治疗进展  

Advances in studies on the therapy of refractory acute myelogenous leukemia

作　　者：王雅茹[1] 张学军[1] 潘崚[1] 

机构地区：[1]河北医科大学第二附属医院血液内科,石家庄050000

出　　处：《国际内科学杂志》2007年第1期29-33,共5页International Journal of Internal Medicine

摘　　要：难治性急性髓性白血病的治疗,仍是当今临床血液学一个难以突破的棘手问题,国内外多种治疗效果均不满意。本文就新型化疗药的应用、传统药物的新用、靶向治疗、造血干细胞移植等方面内容作一综述。The therapy in refractory acute myelogenous leukemia is still one of unbreakthroughable problems in clinic hematology at present. The efficacies of many sorts of therapeutic mathods are dissatisfactory aroud the wortd. As to the use of neotype chemotherapeutic agents, the new use of orthodox drugs, targeted therapy, hematopoietic stem cell transplantation, etc, the article does a reivew.

关 键 词：难治性急性髓性白血病 联合化疗 靶向治疗 造血干细胞移植 

分 类 号：R733.71[医药卫生—肿瘤]